Purchase Order 75N91019P00732
Award Date 9/3/19
Potential Completion Date 9/30/19
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrence, MA 01843, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on September 14, 2020, for scientific equipment on a firm fixed price basis. Performance will occur in Lawrence, Massachusetts, with an ultimate completion date of November 11, 2020. No small business set-aside was applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $24,732.00 on July 17, 2020, for scientific equipment. Performance occurs in Lawrence, Massachusetts. The order uses firm fixed price and carries no small business set-aside. Ultimate completion is August 15, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on August 2, 2018. No set-aside was applied. The order is for lab equipment with a firm fixed price and ultimate completion date of September 28, 2018. Place of performance is Lawrence, Massachusetts.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on July 30, 2020, with an ultimate completion date of August 31, 2020. The order procures scientific equipment on a firm fixed price basis. Performance occurs at Nexcelom's facility in Lawrence, Massachusetts. No set-aside category was applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on May 4, 2018, with performance completion on May 3, 2019. No set-aside was used. Work is performed in Lawrence, Massachusetts. The order is for firm fixed price and covers scientific equipment and related supplies for cell analysis in biomedical research applications.</p>
- <p>The National Cancer Institute issued a purchase order to Nexcelom Bioscience LLC valued at $12,955.00 on December 4, 2019, for a maintenance agreement with an ultimate completion date of December 5, 2020. Performance is located in Lawrence, Massachusetts. The order carries no set-aside designation and employs firm fixed-price pricing.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC on July 19, 2018, with a ceiling value of $12,280.00. Performance is located in Lawrence, Massachusetts. The order is firm fixed price with no small business set-aside applied. Ultimate completion is scheduled for August 18, 2018.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,955.00 on May 31, 2018, for a maintenance agreement, with ultimate completion May 31, 2019. Performance occurs in Lawrence, Massachusetts. The order is firm fixed price with no set-aside applied.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $13,995.00 on September 7, 2017, with completion targeted for October 9, 2017. Work is performed in Bethesda, Maryland. The order is for firm fixed price commercial scientific equipment or related supplies, consistent with Nexcelom's product portfolio of cell analysis and imaging cytometry devices used in biomedical research.</p>
- <p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $139,000.00 on September 5, 2018, for acquisition of a Nexcelom Bioscience Celigo Imaging Cytometer. Place of performance is Lawrence, Massachusetts. The order carries no set-aside designation and has a firm fixed price. Ultimate completion date is October 3, 2018. The award derives from a pre-solicitation posted August 9, 2018, with a due date of August 24, 2018.</p>